Moderna Science Day Highlights Expanding Potential of mRNA Platform
Provides broad overview of Company's research and early development programs expected to continue to fuel future growthHighlights validation of T-cell...
Clinical Trial
Zomedica’s Assisi Loop(R) Products Designated “Fear Free(R)” as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC
Collaboration with Fear Free and Zomedica reinforces Assisi Loop tPEMF™ therapy as a low-stress option for pets. ANN ARBOR, MI...
Phio Pharmaceuticals Announces “How siRNA Therapy can Change the Course of Cancer Treatment” in a Fireside Chat with Force Family Office on Monday, June 29, 2026
Live virtual fireside chat - investors, advisors, and life sciences analysts invited to attendKing of Prussia, Pennsylvania--(Newsfile Corp. - June...
Femasys Regains Compliance with Nasdaq Listing Requirements
ATLANTA, June 24, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and...
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining...
The Quest to Repair What Multiple Sclerosis Takes Away
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over...
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Oncology research is moving through one of its most...
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
Recent Clinical Progress, Enrollment Achievements, Expanded Intellectual Property Portfolio and Strengthened Financial Position Support a Potentially Transformative 12-Month Value Creation...
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World’s Largest Cryptocurrency Exchanges by Spot Trading Volume
Ranked second globally in 24-hour spot trading volume, Gate further extends market access and secondary liquidity for Enlivex’s primary digital...
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
Findings highlight RedTail’s potential to overcome historical limitations of T-cell engagers in solid tumors through tumor-specific, localized expressionSAN DIEGO, June...
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor...
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled trial...
Haag-Streit USA & OHSU Casey Eye Institute announce strategic partnership to advance perimetry program
MASON, Ohio, June 24, 2026 /PRNewswire/ -- Haag-Streit USA, a leading US distributor of high-quality ophthalmic devices, has announced a new...
AI in Healthcare Market to Reach USD 505.6 Billion by 2033, Driven by Rapid Adoption of AI-Powered Clinical Solutions and Digital Healthcare Transformation
Global AI in Healthcare Market Expected to Expand at 38.90% CAGR from 2026 to 2033 as Healthcare Systems Embrace Predictive...
Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England’s 100,000 Genomes Project to Advance Rare Disease Research
Dataset from more than 7,500 participants expands multiomic analysis in rare disease research by combining metabolomics with genomic and clinical...
Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing
Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack MRD...
Precision Neurology Made Practical: Faster Development Through Biomarkers and Real-World Insight, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into how patient identification approaches can improve study efficiency in precision neurology programs. Attendees...
Aspire Biopharma’s BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs
The brand expands nationwide distribution on Amazon, delivering a waterless, rapid-dissolve 50 mg caffeine powder built for active, on-the-go lifestyles....
RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim
The health claims will help drive collaboration with leading international supplement brandsMADRID, June 24, 2026 /PRNewswire/ -- Monteloeder, SL, a...
Yidu Tech’s Gong Yingying at Summer Davos: Building Evidence Infrastructure to Expand Access to Innovative Medicines
DALIAN, China, June 24, 2026 /PRNewswire/ -- On June 23, at the 17th Annual Meeting of the New Champions (Summer Davos...